non-Hodgkin’s lymhpoma

February 25, 2019

Exposure to Glyphosate in Herbicides Increases Risk of Non-Hodgkin’s Lymphoma, Study Says

News

Exposure to glyphosate, a common broad-spectrum herbicide used worldwide, increases the risk of non-Hodgkin’s lymphoma (NHL) by 41 percent in humans, a study says. The study, “Exposure to Glyphosate-Based Herbicides ... Read more

July 19, 2018

Study Examines Prescription Rates for Rituximab Biosimilars in European NHL Patients

News

European patients with non-Hodgkin’s lymphoma (NHL) are more likely to receive rituximab biosimilars if they are fitter, have indolent disease, or follicular lymphoma, according to a new study. The study, “Treatment approach for ... Read more

February 26, 2018February 26, 2018

Umbralisib Shows Promise in Treating Lymphoma, Leukemia in Phase 1 Clinical Trial

News

Umbralisib, being developed by TG Therapeutics, showed positive results in the treatment of chronic lymphocytic leukemia and lymphoma patients in a Phase 1 clinical trial. The study, “Umbralisib, a novel ... Read more

October 24, 2017October 24, 2017

Immune Design’s G100 Receives EMA’s Orphan Drug Designation for Follicular Non-Hodgkin’s Lymphoma

News

The European Medicines Agency (EMA) has granted G100 orphan drug status for the treatment of follicular non-Hodgkin’s lymphoma, Immune Design, the drug’s developer, announced in a press release. The EMA orphan drug designation – ... Read more

February 13, 2017

Jackie Kennedy’s Battle With Non-Hodgkin’s Lymphoma

Jacqueline Kennedy is arguably the most famous First Lady of the United States, known for her grace, style, love of the arts, and for the restoration of the White House—but ... Read more

February 3, 2017

Healthcare Professionals Offer Ways to Improve Cancer-treatment Quality Measures

News

Measures of cancer-treatment quality need to be improved, according to a study that covered 10 forms of the disease, including non-Hodgkin’s lymphoma. The authors identified missed opportunities for improving patient outcomes and, ... Read more